ApprovalTrail

Approval · Notice of Compliance 8020 · 2006

PENLAC: Notice of Compliance 8020

Issued June 13, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
8020
Date
June 13, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Topical antifungal agent

Products in this notice

BrandDINStatus today
PENLAC02250535Dormant

Medicinal ingredients